Healthcare -
Biotechnology - NYSE - US
$ 8.475
2.85 %
$ 487 M
Market Cap
-0.8
P/E
Price Target
Average
--16.72%
Revenue Forecast
Estimate
16.38%
EBIT
Estimate
22.89%
Net Income
Estimate
43.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ginkgo Bioworks Holdings, Inc.
Wall Street analysts predict an average 1-year price target for DNA of $7.06 , with forecasts ranging from
a
low of
$4.35 to a high of $12 .
DNA Lowest Price Target
Wall Street Target
4.35 USD
-48.67%
DNA Average Price Target
Wall Street Target
7.06 USD
-16.72%
DNA Highest Price Target
Wall Street Target
12 USD
41.59%
REVENUE FORECAST
Revenue Forecast Chart DNA
EBIT FORECAST
EBIT Forecast Chart DNA
NET INCOME FORECAST
Net Income Chart DNA